Judge Finds Company’s Offering Documents, Disclosures Not Inherently Misleading
SAN FRANCISCO — A federal judge in California granted a biopharmaceutical company’s motion to dismiss investors’ securities class action against it for allegedly failing to disclose the findings from clinical trials...To view the full article, register now.
Already a subscriber? Click here to view full article